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Mesenchymal stem cells (MSCs) are defined as
cells that undergo sustained in vitro growth and
are able to give rise to multiple mesenchymal
lineages. AlthoughMSCs are already used in re-
generative medicine little is known about their
in vivo behavior and developmental derivation.
Here, we show that the earliest wave of MSC
in the embryonic trunk is generated from Sox1+
neuroepithelium but not frommesoderm. Using
lineage marking by direct gfp knock-in and
Cre-recombinase mediated lineage tracing, we
provide evidence that Sox1+ neuroepithelium
gives rise toMSCs in part through a neural crest
intermediate stage. This pathway can be dis-
tinguished from the pathway through which
Sox1+ cells give rise to oligodendrocytes by ex-
pression of PDGFRb and A2B5. MSC recruit-
ment from this pathway, however, is transient
and is replaced by MSCs from unknown sour-
ces. We conclude that MSC can be defined as
a definite in vivo entity recruited from multiple
developmental origins.
INTRODUCTION
Mesenchymal stem cells (MSCs) have been defined by
two features: the ability to undergo sustained proliferation
in vitro and the potential to give rise to multiple mesenchy-
mal cell lineages including osteocytes, chondrocytes, and
adipocytes (Pittenger et al., 1999; Prockop, 1997). In re-
cent years, MSCs have attracted attention as a source
of cells for use in therapeutic applications for a numberof reasons. First, MSC lines have been isolated from hu-
man and animal tissues, both adult and embryonic (Deans
and Moseley, 2000; Javazon et al., 2004; Pittenger et al.,
1999; Prockop, 1997). Second, the use of MSCs is already
a reality in regenerative medicine (Bianco et al., 2001),
a striking example of which is the recent success in cor-
recting osteogenesis imperfecta (Horwitz et al., 2002). Fi-
nally, recent reports showing the existence of MSC-like
cells (MAPCs) with unexpectedly high potential to give
rise to cells of all three germ layers are expected to open
new avenues into the understanding of the biology of
MSCs (Jiang et al., 2002).
Despite these increased expectations, the most signifi-
cant problem in studying MSCs is the lack of knowledge
concerning their in vivo characteristics, such as their de-
velopment, exact tissue localization, and physiological
role. Because of a difficulty in defining MSCs other than
by the operational definition of in vitro self-renewal and dif-
ferentiation potential, our knowledge of MSCs is solely
based on the characterization of cultured cells (Pittenger
et al., 1999). Development of the CFU-F, a functional as-
say to measure fresh MSCs in tissue (Bianco et al.,
2001; Friedenstein et al., 1970) improved the situation by
defining markers that is exploited for purifying MSCs pro-
spectively (Gronthos et al., 1994). But yet little is known
about the behavior of MSCs in vivo.
The aim of this study is to identify MSC progenitors and
track them prospectively to define MSC differentiation
pathway. For instance, if MSCs are derived from meso-
derm as have been widely believed (Dennis and Charbord,
2002), it should be possible to define their development
prospectively by investigating whether purifiedmesoderm
cells can give rise to MSCs. Once the earliest progenitor is
identified, there are various ways to identify intermediate
stages in the MSC differentiation pathway. To this end,
we exploited ES cell cultures that support differentiationCell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc. 1377
Figure 1. Two Distinct Pathways of ES Cell Differentiation to
Adipocytes
(A) Two protocols for inducing adipocytes from ES cells. Condition A:
Culture on a collagen IV-coated dish with serum containing medium.
Condition B: Incubation with 107 M Retinoic Acid (RA) from day 2 to
day 5 under serum containing medium. The medium was replaced
by a RA-free secondary culture on day 5. Under both conditions, adi-
pogenesis was induced by a cocktail of adipogenic reagents (see Sup-
plemental Experimental Procedures) added from day 11.
(B) Generation of PDGFRa+ cells during ES cell differentiation under
the two conditions. The proportion of PDGFRa+ cells peaked on day 4
and day 9 under Condition A and B, respectively.
(C) Analysis of adipogenic activity. PDGFRa+ and PDGFRa cells (data
not shown) were purified from day 4 (Condition A) or day 9 (Condition B)
cultures, and 5 3 105 cells were re-cultured under adipogenic condi-
tions. Oil red O staining of at day 18 (Condition B) and day 25 (Condi-
tion A). Only PDGFRa+ cells are adipogenic. Condition B is more
efficient than Condition A in adipogenic activity as indicated by the1378 Cell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc.of various mesenchymal cell lineages (Kawaguchi et al.,
2005; Sakurai et al., 2006; Wobus et al., 2002), as it is eas-
ier to dissect the differentiation process in vitro than in the
living embryo. Thus, we began this study by attempting to
define MSC progenitors in the in vitro differentiation of ES
cells to adipocytes. Here, we present evidence that Sox1+
neuroepithelial cells supply the earliest wave of MSC dif-
ferentiation, which occurs during embryogenesis but is
later replaced by MSCs from other origins in postnatal
development.
RESULTS
MSCs Generated in ES Cell Culture Are Derived
from Neuroepithelium but Not from Mesoderm
In order to specify the culture condition for ES cell differen-
tiation toMSC, we compared twomethods that have been
used for inducingmesenchymal cell lineages fromES cells
(Figure 1A). The first condition (Condition A) is culture on
collagen IV-coated dish under serum-containing medium,
which supports generation of mesodermal cells that give
rise to osteocytes, chondrocytes and myocytes (Sakurai
et al., 2006). The other method involves the treatment of
ES cells with pulse exposures to retinoic acid (RA) from
day 2 to day 5 of culture (Condition B) followed by incuba-
tion under the adipocyte-inducing condition from day 11
(Dani et al., 1997).
Cells expressing PDGFRa that is expressed in mesen-
chymal cells including adipocytes (Drozdoff and Pledger,
1991) were generated under both culture condition, but
they reached a peak on day 4 under Condition A and on
day 9 under Condition B (Figure 1B). Under both condi-
tions, adipogenic activity was detected only in the
PDGFRa+ population (Figure 1C). With respect to the effi-
ciency of adipogenesis as assessed by the TG content of
the cultures, Condition B showed 10-fold higher activity
than Condition A (Figure 1C).
We then assayed the ability of MSCs to undergo sus-
tained proliferation in vitro. Under the culture condition
for maintaining MSC lines established from bone marrow
triglyceride content in the inset of each panel (mean of triplicate cul-
tures and standard deviation).
(D) PDGFRa+ cells induced under Condition B but not Condition A
underwent sustained growth in vitro. In vitro growth of PDGFRa+ cells
from cultures under Condition A and under Condition B were com-
pared.
(E) RT-PCR analysis of lineage markers in MSC lines established from
PDGFRa+ cells induced under Condition B. OB-CAD, Vimentin and
PDGFRb for mesenchymal lineage, Brachyury, Mesp2 and Mesogenin
for mesoderm, and Sox10 and Wnt1 for neural crest (Matsuoka et al.,
2005; Sakurai et al., 2006; Tada et al., 2005).
(F) Multipotency of MSC lines derived from PDGFRa+ cells in Condition
B culture. (a) Phase-contrast view. (b–d) Multipotency of MSC clones.
Clones were established from bulk culture of MSCs, and their potential
to give rise to adipocytes (b, Oil red O staining on day 10), osteocytes
(c, Alizarin red staining on day 28), and chondrocytes (d, Alcian blue
staining on day 21) was analyzed. One-third of clones gave rise to all
three lineages.
Figure 2. Sox1+ Cells in ES Cell Culture
Are Definite Progenitors of MSCs
(A) Expression of mesoderm and mesenchyme
markers in PDGFRa+ cells induced under Con-
ditions A and B. PDGFRa+ cells induced under
each condition were purified and expression
of molecular markers was evaluated by RT-
PCR. Brachyury, Mesp2, and Mesogenin are
markers for mesoderm andOB-CAD, Vimentin,
and PDGFRa are common markers for mesen-
chymal cells.
(B) Expression of molecular markers for meso-
derm, endoderm (GATA4, Foxa2), and neural
lineages during ES cell differentiation under
Conditions A and B. Cells were harvested every
day from day 2 to day 5 and marker expression
was examined by RT-PCR. Note that Condition
A supports mesoderm and endoderm differen-
tiation whereas Condition B does neural differ-
entiation assessed by neural cell markers
described previously (Li, 2002; McCormick
et al., 1996).
(C) The kinetics of differentiation of Sox1+ and
PDGFRa+ cells under Condition B. GFP+ cells
peaked on day 4 but no PDGFRa+ cells were
detected in the culture up to day 4.
(D) Expression of neural and mesoderm
markers in Sox1-GFP+ cells by RT-PCR analy-
sis. No mesoderm markers are expressed.
(E) Generation of PDGFRa+ cells from purified
Sox1+ cells. The Sox1+ and Sox1 populations
purified from day 4 cultures under Condition B
are re-cultured for 6 more days. PDGFRa+ cells
were generated only from Sox1+ population.
(F) Expression of lineage markers in Sox1+-
derived PDGFRa+ cells by RT-PCR. Note that
mesenchymal- but no neural- and mesoder-
mal-markers are detected.
(G) Adipogenic activity of cell fractions har-
vested from day 10 culture. Sox1+ and Sox1
cells were purified from day 4 culture under
Condition B, re-cultured for 6 more days, and
separated into PDGFRa+ and PDGFRa frac-
tions. Each fraction was re-cultured with adipo-
cyte induction cocktail for 8 days. Adipocytes
visualized by Oil red O staining were detected
only in the PDGFRa+ fraction derived from
Sox1+ cells.and adipose tissue (MSC condition) (Pittenger et al.,
1999), the PDGFRa+ population induced under Condition
B, but not A, exhibited sustained growth (Figure 1D).
Moreover, they underwent clonogenic growth and devel-
oped into fibroblast-like cell clones (a in Figure 1F) that ex-
pressed molecular markers of mesenchymal cell lineage
such asOB-CAD andPDGFRb ; they did not, however, ex-
press markers of mesoderm or neural crest (Figure 1E). Of
10 clonal lines established, three lines gave rise to adipo-
cytes, chondrocytes, and osteocytes (b-d in Figure 1F).
These results suggest that only PDGFRa+ population
induced under Condition B contains MSC progenitors.
Considering our previous study that Condition A is the
optimum for mesoderm differentiation, this result sug-
gests that MSCs generated in the ES cell culture are notderived from mesoderm. Indeed, no paraxial mesoderm
markers (Figure 2A, Brachyury, Mesp2, and Mesogenin)
were expressed in the PDGFRa+ population induced by
Condition B, whereas they were detected in the PDGFRa+
population induced by Condition A. Though clearly
distinctive each other, the two populations express com-
mon mesenchymal markers such as OB-CAD and
PDGFRb (Figure 2A). Taken together, the two PDGFRa+
populations represent mesenchymal lineage but derived
from distinct pathways.
To gain an insight into their origins, we assessed the ex-
pression of molecular markers for mesoderm, endoderm,
and neural lineages of cells cultured under the two condi-
tions. Mesoderm and endoderm markers were expressed
under Condition A, but not B (Figure 2B). In contrast,Cell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc. 1379
Figure 3. Sox1+ Neuroepithelial Cells Are
Sole Population of E9.5 Embryos that
Can Give Rise to MSCs In Vitro
(A) GFP expression of a tetraploid chimera from
ES-Sox1gfp/+ cells. Whole-mount view under
fluorescent microscope (left panel) and section
staining with anti-GFP (center panel). Approxi-
mately 20% of blastocysts injected with
ES-Sox1gfp/+ cells developed to E9.5 embryos.
Note that GFP expression is restricted in the
neural tube. Trunks (indicated by white lines
in the left panel) of embryos were pooled, dis-
sociated, and analyzed for GFP and PDGFRa
expressions by flow cytometer. Expression of
Sox1-GFP and PDGFRa were completely seg-
regated (right panel).
(B) Adipogenic activity of Sox1+PDGFRa and
Sox1PDGFRa+ cells purified from E9.5 em-
bryos. Adipogenesis was assessed by Oil red
O staining. Sox1+PDGFRa cells generated
more adipocytes than Sox1PDGFRa+ cells.
(C) Growth activity of Sox1+ and PDGFRa+
populations from E9.5 tetraploid embryos.
Only Sox1+PDGFRa cells underwent sus-
tained growth under MSC condition (mean
value of triplicate culture).
(D) Differentiation of PDGFRa+ cells from
Sox1+PDGFRa cells in E9.5 embryos.
Sox1+PDGFRadifferentiate toSox1PDGFRa+,
Sox1+PDGFRa and double-negative cells.
(E) Multi-lineage differentiation from MSC clones
derived from Sox1PDGFRa+ cells generated
from Sox1+ cells of E9.5 embryos. Cloned cell
lines were fibroblast-like in morphology (far left)
and could give rise to adipocytes (left, Oil red O
staining on day 14), osteocytes (right, Alizarin
red staining on day 35), and chondrocytes (far
right, Alcian blue staining on day 28).expression of neural markers was detected only under
Condition B. Thus, the next issue is whether or not
PDGFRa+ MSC induced under Condition B are actually
derived from neural lineage. In order to define neural line-
age, we used Sox1 as amolecular marker, as it was shown
to be the most specific marker for neuroepithelial cells
(Aubert et al., 2003; Pevny et al., 1998). To visualize the
Sox1+ neuroepithelial cells, we used an ES cell line to
which the gfp gene has been inserted in the sox1 allele
(ES-Sox1gfp/+) (Aubert et al., 2003). As expected, Condi-
tion B supports preferential differentiation to Sox1+ cells
(Figures 2C and 2D). We then investigate whether or not
Sox1+ neuroepithelium can give rise to PDGFRa+ MSC.
GFP+ but not GFP population in day 4 culture of ES-
Sox1gfp/+ cells under Condition B could give rise to adipo-
cytes (Figure 1A in the Supplemental Data available with
this article online). Neither GFP+ nor GFP cells expressed
PDGFRa at day 4, but on culturing the sorted cells for 6
more days, the PDGFRa+ population reached 30%–40%
in the culture of GFP+ cells (n = 3), whereas only a low level
of PDGFRa+ was induced from the GFP cells (Figure 2E).
These Sox1+-derived PDGFRa+ cells have already lost1380 Cell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc.neural and neural crest markers such as Sox1, Sox10
and Wnt1 (Figure 2F). Adipocytes were generated only
from the PDGFRa+ population in the culture of Sox1+ cells
(Figure 2G). Moreover, this PDGFRa+ population had the
potential to undergo sustained in vitro growth (data not
shown) and to give rise to MSC lines that can give rise to
the three lineages of adipocytes, chondrocytes, and oste-
ocytes (Figure S1B). Taken together, Sox1+PDGFRa and
subsequent Sox1PDGFRa+ populations are successive
intermediates in a MSC differentiation pathway.
Sox1+ MSC Progenitors in Early Embryos
We next attempted to confirm this differentiation pathway
in the embryo. ES-Sox1gfp/+ were aggregated with tetra-
ploid embyos (Nagy et al., 1993), incubated in utero and
harvested at E9.5. In this embryo, GFP expression was
detected almost exclusively in neuroepithelial cells (Fig-
ure 3A), whereas somitic cells are present in PDGFRa+
population (Takakura et al., 1997). We removed the cranial
and tail regions upon preparing single-cell suspension of
embryonic cells, as cranial neuroepithelial cells normally
give rise to mesenchymal cell lineages through the neural
Figure 4. Tracing of Cells Derived from
Sox1+ Neuroepithelial Cells and P0+
Neural Crest Cells in Embryos
In Sox1-Cre/YFP embryos, YFP expression
was detected in the neuroepithelium at E8.5
(A and D), E9.5 (B, E, and G) and E11.5 (H).
PDGFRa expression (red color in [D] and [G])
is detected in the somite. In E9.5 and E11.5 em-
bryos, YFP+ cells become detectable outside
the neural tube such as branchyal arch (arrow
in [E]) and dorsal root ganglia (arrow in [H]). In
contrast, no YFP expression is detected in
the neural tube of P0-Cre/YFP embryo at E9.5
(C and F) and E11.5 (I). On the other hand,
YFP is expressed in neural crest of branchial
arches (arrow in [F]) and neural crest-
derived tissues such as cranial mesenchyme
(C), otic vesicle (C and F) and dorsal root gan-
glia (arrow in [I]).crest (Le Douarin et al., 2004). Cells dissociated from
the trunks of E9.5 embryos were divided into three
populations, Sox1PDGFRa+, Sox1+PDGFRa, and
Sox1PDGFRa; no double-positive cells were detected
(right panel in Figure 3A). Expression of molecular markers
confirmed that Sox1+PDGFRa cells from the trunk cor-
respond to neuroepithelium and Sox1-PDGFRa+ cells
contain mesodermal but not neural cells (Figure S1C).
Consistent with our in vitro experiments, adipocytes dif-
ferentiated from both Sox1+ and PDGFRa+ populations
(Figure 3B), but only Sox1+ cells underwent sustained
growth under MSC condition (Figure 3C). In separate
experiments, we confirmed that cells expressing
endodermal makers were present in the double negative
fraction and failed to give rise to MSCs nor adipocytes
(Figure S1C).
In all attempts (n = 3), multipotent MSC lines could be
established directly from Sox1+ cells. Moreover, Sox1
PDGFRa+ cells were generated by incubating Sox1+
PDGFRa cells in culture (Figure 3D). Thus, in complete
agreement with our in vitro results, only Sox1+ neuroepi-
thelial cells in the trunk of E9.5 embryo contain MSC pro-
genitors. While it was difficult to establish MSC clones di-
rectly from Sox1+ cells in the embryo, a fraction (7/576) of
PDGFRa+ cells that were induced by 6-day incubation of
FACS-purified Sox1+ cells could undergo sustained clo-
nogenic growth. Among them, three clones maintained
the potential to give rise to adipocytes, chondrocytes,
and osteocytes under conditions appropriate to those lin-
eages (Figure 3E).Persistent Labeling of Sox1+ Neuroepithelial Cells
and P0+ Neural Crest Cells
To determine the correlation between Sox1+ MSC pro-
genitors in E9.5 embryos andMSCs in later life, we carried
out a persistent labeling experiment of Sox1+ cells (Sor-
iano, 1999). For this experiment, we exploited the Cre-
recombinase-mediated labeling method by inserting Cre
gene in the Sox1 allele (see Experimental Procedures
and Figure S2A), and the resulting mice were crossed to
the ROSA26R-EYFP strain, whose YFP expression was
switched on by Cre-recombinase and constitutively main-
tained under ROSA promoter (Srinivas et al., 2001). Con-
sidering the possibility that Sox1+ neuroepithelial cells
give rise to MSCs via the neural crest stage, we also
used P0-Cre/YFP embryos. As compared with Wnt1 that
is also used for neural crest labeling but expressed in
the dorsal region of the neural tube (Parr et al., 1993; Pietri
et al., 2003), the P0 promoter expresses genes only after
the differentiation of neural crest cells (Yamauchi et al.,
1999).
In the Sox1-Cre/YFP embryos, YFP expression was de-
tected in the neural fold of E8.5 embryos and in the neural
tube of E9.5 embryos (Figures 4A, 4B, 4D, and 4E). Pro-
portion of YFP+ cells (more than 80%) was mainatained
at the same level in the central nervous system up to adult
stage (Figure S4E). Sox1 expression was segregated
completely from the somites and restricted to the neuroe-
pithelium in the trunk (Figure 4G). While YFP expression in
first branchial arch is low (Figure 4E), nearly all neural
tubes and dorsal root ganglia (DRG) of E11.5 embryosCell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc. 1381
Figure 5. Presence of MSCs Derived from Sox1+ Neuroepi-
thelium and P0+ Neural Crest in Embryos
(A) FACS analysis of YFP and PDGFRa expression in E14.5 Sox1-Cre/
YFP (left) and P0-Cre/YFP (right) embryos. The trunk region of Sox1-
Cre/YFP and P0-Cre/YFP E14.5 embryos were pooled and dissoci-
ated. YFP+PDGFRa+ cells were detected in both strains.
(B) PDGFRa+ expression of CFU-F. Each fraction indicated in the
figure was purified from Sox1-Cre/YFP (left) or P0-Cre/YFP (right)
embryos at E14.5, and CFU-F assay was performed. Upper pictures
show colonies developed in each dish. The number of colonies is
shown in the lower graphs. Each bar represents the arithmetic mean
and SD of triplicate assays. CFU-F activitiy was enriched in PDGFRa+
populations irrespective of YFP expression.
(C) In vitro proliferative activity of PDGFRa+ populations in E14.5
embryo. Irrespective of YFP expression, PDGFRa+ cells can undergo
sustained proliferation in the MSC culture condition.1382 Cell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc.were YFP+ (Figure 4H), suggesting that labeling efficiency
per se is high. In contrast, in P0-Cre/YFP embryos, YFP
expression was mainly observed in branchial arches and
cranial mesenchymal tissues (Figures 4C and 4F) but not
in neural tube. At E11.5, YFP expression was not detected
in the neural tube, but was in the dorsal root ganglia
(Figure 4I).
MSCs in Embryos Are Recruited
from Multiple Sources
Using the Sox1-Cre/YFP mice, we first explored the pres-
ence of PDGFRa+ cells derived from Sox1+ cells in E14.5
embryos. Again, we prepared cell suspensions only from
the trunk region. YFP+PDGFRa+ cells were detected in
the trunk region of the two mouse strains (Figure 5A).
Thus, a PDGFRa+ population derived from Sox1+ neuroe-
pithelial cells as well as from P0+ neural crest cells are
present in the trunk of the embryos. PCR analyis showed
that YFP+ cells from the trunk of E14.5 embryo no longer
express endogenous Sox1 as well as Cre, suggesting
that they are the progeny of Sox1+ neuroepithelial cells
generated before E14.5 (upper panel in Figure S2B). In
contrast, Cre expression is still observed in YFP+ cells
from E14.5 P0-Cre/YFP embryos (lower panel in Fig-
ure S2B), suggesting sustained expression of P0 in
some neural crest lineages. Section analysis showed
that almost all YFP expression is detected in neural
crest-derived tissues such as dorsal root ganglia (Fig-
ure 4I), and YFP+PDGFRa cells expressed Sox10, a
marker of trunk neural crest (lower panel in Figure S2B).
Interestingly, the proportion of YFP+PDGFRa+ cells in
the cell suspension from the trunk of Sox1-Cre/YFP em-
bryos was 8-fold less than that from P0-Cre/YFP embryos
(Figure 5A). This suggests that a considerable proportion
of neural crest cells that differentiate to PDGFRa+ cells
do not originate from Sox1+ neuroepithelial cells. The
same may be also the case for cranial region, as YFP+
cells in the mesenchymal population of the first branchial
arch was far lower in Sox1-Cre/YFP embryos than in P0-
Cre/YFP embryos (Figures 4E and 4F).
Nonetheless, we found PDGFRa+ cells derived both
from neuroepithelial cells and from neural crest cells in
the trunk of E14.5 embryo. The YFP+PDGFRa+ popula-
tions from the Sox1-Cre/YFP and P0-Cre/YFP embryos
were sorted and assayed for the potential to give rise to
MSCs and CFU-F (Figure 5B). Both populations ex-
pressed mesenchymal markers, such as OB-CAD and
PDGFRb (Figure S2B). CFU-F was detected at the same
frequency in the YFPPDGFRa+ and YFP+PDGFRa+ pop-
ulations in both stains of embryo, but almost no CFU-F
was detected in the PDGFRa populations, irrespective
(D) Multipotency of MSC clones. MSC clones were established from
YFP+PDGFRa+ cells in E14.5 Sox1-Cre/YFP embryos and examined
their ability to give rise to adipocytes (left, Oil red O staining on
day 14), osteocytes (center, Alizarin red staining on day 42), and chon-
drocytes (right, Alcian blue staining on day 35).
Figure 6. Distinction between Oligodendrocyte and MSC in PDGFRa+ Population Derived from Sox1+ Neuroepithelial Cells
(A) Expression of PDGFRb and A2B5 in YFP+PDGFRa+ cells in E14.5 Sox1-Cre/YFP embryos. The single-cell suspension was prepared only from the
trunk region. YFP+PDGFRa+ cells are segregated to two distinct populations, A2B5PDGFRb+/weak and A2B5+PDGFRb.
(B) Expression of neural markers in the PDGFRb+ and A2B5+ populations. YFP+PDGFRa+ cells in E14.5 Sox1-Cre/YFP embryos were further divided
into A2B5+ and PDGFRb+ populations and expression of neural cell markers in each fraction was evaluated by RT-PCR. Sox10, Olig1 and 2, MAP2,
and Sox2 were used for markers for neural lineage including oligodendrocytes. Neural markers are not detected in PDGFRb+ nor A2B5 population,
whereas detected in PDGFRb and A2B5+ cells.
(C) CFU-F activity in PDGFRb+ cells. PDGFRb+ cells but not PDGFRb cells in YFP+PDGFRa+ cells have a potential to form CFU-F. (mean and SD of
triplicate cultures).
(D) In vitro proliferative activity of PDGFRb+ population. PDGFRb+ and PDGFRb populations were cultured under MSC condition. Only PDGFRb+
cells underwent sustained growth.
(E) Adipogenic activity of PDGFRb+ cells in YFP+PDGFRa+ populations. Adipogenesis was assessed by Oil red O staining (left panel) or expression of
adipocyte specific genes, PPARg and adiponectin (right panels).of YFP expression. Moreover, YFP+PDGFRa+ and YFP
PDGFRa+ cells of both mouse strains exhibited sustained
growth in vitro (Figure 5C). These results strongly suggest
that the MSC progenitors in the trunk of E14.5 embryos
are PDGFRa+ but derived not only from neural crest but
also from other, as yet unidentified, sources. We also
confirmed the multipotentiality of MSC established
from YFP+PDGFRa+population of Sox1-Cre/YFP mice
(Figure 5D).
MSC Progenitors Are Distinguished from
Oligodendrocyte Precursors by Expression
of PDGFRb and A2B5
YFP+PDGFRa+ cells in the trunk of E14.5 Sox1-Cre/YFP
embryos are likely to contain oligodendrocyte (OG) pre-
cursors (OGPs) generated in the neural tube (Stolt et al.,
2006). We thus investigated whether or not MSCs in the
PDGFRa+ population derived from Sox1+ cells in E14.5
embryos are different from OGPs that express A2B5(Kondo and Raff, 2000). YFP+ PDGFRa+ cells in E14.5
Sox1-Cre/YFP mice contain both A2B5+ and PDGFRb+
populations. Interestingly, the two populations are segre-
gated almost completely (Figure 6A). By RT-PCR analysis,
markers for OGs are detected only in A2B5+ population
(Figure 6B). Sorted A2B5+ population could form neuro-
sphere upon culturing under the condition described in
previous reports (Morrison et al., 1999) (Figure S3A),
whereas could not undergo sustained growth under
MSC condition nor give rise to adipocytes (data not
shown). As those neurosphere could give rise to OG,
A2B5+ cells derived from Sox1+ neuroepithelium are
OGP with self-renewing capacity (Figure S3B). The
PDGFRb+ population expresses none of OG markers
used in this study and failed to form the neurospheres (Fig-
ures 6B and S3A). CFU-Fs are enriched in the PDGFRb+
population (Figure 6C). In addition, this population un-
dergoes sustained growth and gives rise to adipocytes
(Figures 6D and 6E). Cells isolated from individual CFU-FsCell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc. 1383
Figure 7. Presence of Neuroepithelium-Derived and Neural
Crest-Derived MSCs in Postnatal Bone Preparation
Femoral and tibial bones were removed from neonatal and 4-week-old
mice, minced, and incubated with a 0.2% collagenase+2.4U dispase
cocktail to prepare single-cell suspension.
(A) Expression of YFP and PDGFRa in the neonates of Sox1-Cre/YFP
(left panel) and P0-Cre/YFP (right panel) mice. The proportion of1384 Cell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc.gave rise to adipocytes but not OG (data not shown). The
frequency of CFU-F in YFP+PDGFRa+PDGFRb+ popula-
tion was 2%, and 50% of the colonies could develop to
adipogenic cell lines. Thus, OGPs and MSCs, which are
derived from neuroepithelium and express PDGFRa are
fully segregated, respectively, to A2B5+ and PDGFRb+
fractions at E14.5.
Transient Wave of MSC Generation
from Neuroepithelial and Neural Crest Lineages
As bone and bone marrow has been the major sources of
MSC (Deans andMoseley, 2000; Javazon et al., 2004), we
focused the analysis of postnatal mice on cells dissoci-
ated from femoral and tibial bones by treatment with
collagenase and dispase. YFP+PDGFRa+ cells were de-
tected in the bone cell preparation of neonates, 4-week
and 12-week old mice of Sox1-Cre/YFP and P0-Cre/
YFP (Figures 7A, 7B, and S4A). However, the proportion
of YFP+PDGFRa+ cells in the bone cell preparation of ne-
onates was far lower than in the whole embryonic trunk,
and the population significantly decreased with age in
both Sox1-Cre/YFP and P0-Cre/YFP mice (Figure 7C).
This is consistent with the result showing low expression
of Ki67, suggesting MSCs derived from Sox1+ neuroepi-
thelium do not proliferate after birth (Figures S4B and
S4C). Similarly, YFPPDGFRa+ in the bone cell prepara-
tion of both mice decreased along with neonatal develop-
ment (Figures 7A, 7B, and S4A). Notably, CFU-F activity
was found at the same level both in YFP+PDGFRa+ and
YFPPDGFRa+ populations representing, respectively,
neural crest and nonneural crest pathways (Figure 7D).
The ability of YFP+PDGFRa+ cells to give rise to the multi-
potent MSC was also confirmed, as before (Figure 7E).
Thus, PDGFRa+ population in the bone preparation of
postnatal mouse contains MSCs derived from neuro-
epithelium and neural crest, but their contribution is not
YFP+PDGFRa+ population is much lower than that of YFPPDGFRa+
population in both stains.
(B) The same assay of 4-week old Sox1-Cre/YFP (left panel) and
P0-Cre/YFP(right panel) mice. Only a few PDGFRa+ cells are detect-
able at this stage, irrespective of YFP expression.
(C) The proportions of neuroepithelium- and neural crest-derived cells
in neonatal and 4-week-old mice as assessed by YFP expression.
Note that the postnatal decrease is more conspicuous in PDGFRa+
population than PDGFRa one. Each value represents the arithmetic
mean and SD of three mice (*p < 0.05, **p < 0.01).
(D) Enrichment of CFU-F activity in PDGFRa+ populations of neonates.
Each fraction indicated in the figure was purified from the femoral and
tibial bones of Sox1-Cre/YFP (left) or P0-Cre/YFP (right) neonates and
frequency of CFU-F was examined. Upper panels show the colonies in
representative dishes. The number of colonies in each fraction is
shown in the lower graphs. Each bar represents the arithmetic mean
and SDof triplicate assays. Like fetal tissues, CFU-F activities were en-
riched in PDGFRa+ populations irrespective of YFP expression.
(E) Multipotency of MSC clones derived from bones of Sox1-Cre/YFP
neonates. MSC clones established from YFP+PDGFRa+ fraction could
give rise to adipocytes (left, Oil red O staining on day 14), osteocytes
(center, Alizarin red staining on day 42), and chondrocytes (right, Alcian
blue staining on day 35).
high. Moreover, they rapidly decrease during neonatal de-
velopment (Figures 7A–7C and S4A). As the YFP expres-
sion in central nervous system is maintained at the same
level during postnatal development and YFP expression
of MSC does not fade during culture, it is unlikely that de-
crease of YFP+ population during postnatal development
is due to silencing of the YFP gene (Figures S4D and
S4E). Taken together, these results suggest that MSCs
are differentiated through multiple routes with distinct
cellular origins, among which the wave originating from
neuroepithelium including the neural crest, although it is
transient, is the earliest.
DISCUSSION
The aim of this study was to define the developmental
pathway ofMSCs, which is largely unstudied in vivo.While
we demonstrated two pathways for adipocyte differentia-
tion, one from Sox1PDGFRa+ paraxial mesoderm and
the other fromSox1+ neuroepithelium; only the latter could
give rise to MSCs. This observation in ES cell culture was
confirmed in E9.5 embryos. In the embryo, it is well estab-
lished that cranial neural crest cells give rise to mesenchy-
mal cells (LaBonne and Bronner-Fraser, 1999; Le Douarin
et al., 2004). To avoid unnecessary confusion, this study
focused only on the trunk region. We obtained PDGFRa+
somitic cells and Sox1+ neuroepithelium from the trunk,
which are segregated each other in FACS analysis (Fig-
ure 3A). Consistent with the in vitro result, Sox1+ neuroe-
pithelium in the trunk did give rise to MSCs. While somitic
cells have been believed as progenitors of MSCs, none of
the PDGFRa+ cells in the E9.5 embryos could differentiate
to MSCs, although they could give rise to adipocytes.
Thus, the first MSC progenitors in the embryo, which are
identifiable by the method herein, are derived from neuro-
epithelial cells. This observation, however, does not rule
out a possibility that paraxial mesoderm has potential to
give rise to MSCs under other appropriate conditions.
In the ES cell culture system, Sox1PDGFRa+MSCpro-
genitors induced from Sox1+ cells are negative for neural
crest markers such as Sox10 and Wnt1 (Figure 2F). We
are however convinced that at least a part of MSCs pass
through the neural crest stage during differentiation from
Sox1+ cells to PDGFRa+ MSCs, as Sox10 is induced dur-
ing the culture of Sox1+ cells (data not shown). We also
investigated the expression p75, another neural crest
marker (Morrison et al., 1999; Wilson et al., 2004), in cells
derived from Sox1+ neuroepithelial cells. Consistent with
the previous study (Wilson et al., 2004), p75 expression
coincides with neural crest cells at E9.5 (Figures S5A
and S5B). Though PDGFRa has not been expressed in
Sox1+ cells at E9.5 (Figures 3A and S5C), we could detect
p75+PDGFRa+ population derived from Sox1+ cells at
E14.5 and this population contained CFU-F (Figures S5C
and S5D). This observation also supports presence of
neural crest pathway for MSCs differentiation, though
p75PDGFRa+ cells also contain CFU-F.The presence of neural crest-derived MSCs was also
confirmed by Cre-recombinase-mediated genetic label-
ing method (Kilby et al., 1993). In this study, we compared
Sox1-Cre/YFP embryos with P0-Cre/YFP embryos in
which neural crest derived cells are labeled. In both
strains, YFP+ cells that have an ability to form CFU-F
were detected in the PDGFRa+ population. Thus, in the
embryo, at least a part of the earliest wave of MSCs are
generated through Sox1+ neuroepithelium, P0+ neural
crest and Sox1PDGFRa+ progenitor.
We have shown that Sox1+ cells in the trunk region can
give rise to PDGFRa+ mesenchymal cell lineages, which
contrasts to the widely accepted view that trunk neural
crest cells do not contribute to mesenchymal cell lineages
in normal development (Le Douarin et al., 2004). It has
been suggested that trunk neural tube has the ability to
give rise to mesenchymal cells (Shah et al., 1996). More-
over, a recent fate analysis of neural crest cells by persis-
tent labeling demonstrated that trunk neural crest cells
differentiate to myofibroblasts in the endoneural region
(Joseph et al., 2004). These endoneural myofibroblast lin-
eages may be identical to the neural crest-derived MSCs
in the embryonic trunk. However, as cranial neural crest
cells are also distributed in the trunk (Matsuoka et al.,
2005), it has been difficult to determine the origin of neural
crest cells in the trunk. In this respect, this study would be
the clearest demonstration that trunk neural crest cells do
give rise to mesenchymal lineages, as the contamination
of cranial neural crest in Sox1+ trunk neuroepithelium is
unlikely.
Another unexpected observation from our persistent
labeling experiment is that PDGFRa+ cells labeled by
Sox1-Cre were 8-fold fewer than those labeled by P0-Cre.
According to one current model, neural crest cells are
derived mostly from the dorsal part of the neural tube
(LaBonne and Bronner-Fraser, 1999). If this is the case,
Sox1-Cre should label all neural crest cells. It could be
that the lower frequency of mesenchymal cells marked
by Sox1-Cre may simply reflect low recombinase activity.
However, Sox1-Cre was efficient in labeling other neuro-
epithelium-derived lineages, as nearly all neuroepthelial
cells at E9.5, dorsal root ganglia cells and melanocytes
(Figure S6) are YFP+ in Sox1-Cre/YFP mice. These results
may suggest that Sox1+ neuroepithelial cells are not the
sole source of neural crest cells. Recently, we proposed
a hypothesis that ectodermal cells in close proximity to
neuroepithelial cells are the actual source of cranial mes-
enchymal cells (Weston et al., 2004). The present study
partly supports this hypothesis, though it shows at the
same time that Sox1+ neuroepithelial cells do contribute
to ectomesenchymal cells.
We were able to specify MSCs derived both from Sox1+
neuroepithelial cells and neural crest cells. In the in vitro
CFU-F assay, about 1/40 of the YFP+PDGFRa+ cells
in the embryo and 1/4 of those in the neonatal bone
preparation formed colonies, whereas almost no YFP+
PDGFRa cells did so. Thus, MSC progenitors are highly
enriched in the PDGFRa+ population of neonatal boneCell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc. 1385
marrow. YFP+PDGFRa+ cells from Sox1-Cre/YFP mice
also exhibited sustained growth on transfer toMSC condi-
tion, and multipotent MSC lines were established from
them. This MSC progenitor is explicitly distinguished from
oligodendrocyte progenitor by expression of PDGFRb
and A2B5.
Though in E9.5 embryo Sox1+ cells are the only popula-
tion that can give rise to PDGFRa+ MSCs, MSCs derived
from neuroepithelium appeared to be a transient popula-
tion that is eventually replaced by those derived from
unidentified pathways. Indeed, already in the E14.5 em-
bryonic trunk, the proportions of YFPPDGFRa+ cells
were 21% and 13% for Sox1-Cre/YFP and P0-Cre/YFP
embryos, respectively, which are higher than those of
YFP+PDGFRa+ cells (1.3% and 9.4%, respectively). As
the same levels of CFU-F are present in YFP+ and YFP
populations, and MSCs could be established from both
populations, the YFP population does contain bona
fide MSCs. Taken together, these results suggest that a
significant proportion of MSCs in E14.5 embryos are
already derived from a nonneural crest pathway.
In this study, we showed that neuroepithelium-derived
and neural crest-derived MSCs are present also in the
cell preparation from femoral and tibial bones of postnatal
mice. However, the proportions of neural crest-derived as
well as neuroepithelium-derived MSCs decrease progres-
sively over the course of development, and the contribu-
tions of YFP+ cells to PDGFRa+ cells in the bone cell prep-
aration were 0.032% and 2.39% for Sox1-Cre/YFP and
P0-Cre/YFP neonates, respectively. Moreover, the fre-
quency of CFU-F in the PDGFRa+ population was nearly
the same in YFP+ and YFP cells. Thus, in the neonatal
bone preparation, MSCs were enriched in PDGFRa+ but
most of them were derived from a nonneural crest path-
way. As mice age, YFP+PDGFRa+ cells practically disap-
peared from the bone preparation of both Sox1-Cre/YFP
and P0-Cre/YFP strains. Taken together, these results
suggest that the MSC differentiation pathway defined in
this study represents the earliest, but transient, wave of
MSC supply.
The concept of MSCs originating in multiple waves de-
rived from distinct sources is reminiscent of various other
stem cell systems. Hematopoiesis is divided into primitive
and definitive hematopoiesis, which originate from distinct
regions (Zon, 1995). As for mesenchymal cell lineages,
a recent study showed that skeletal muscle cells are re-
cruited through multiple waves derived from distinct path-
ways (Bailey et al., 2001). We have shown here that the
earliest wave of MSC generation originates in the neuro-
epithelial and neural crest cells. However, the derivation
of the later waves remains for future investigation. While
we speculate that mesoderm cells remain one possible
source, a recent study suggests that hematopoietic cells
may constitute the progenitors of MSCs in adult bone
marrow (Ogawa et al., 2006).
To our knowledge, no experimental evidence is avail-
able for the origin of MSCs. Recently, however, neural
crest cells have emerged as another potential source.1386 Cell 129, 1377–1388, June 29, 2007 ª2007 Elsevier Inc.Firstly, it is well established that neural crest cells are mul-
tipotent progenitors with the potential to give rise to a wide
variety of tissue cells (LaBonne and Bronner-Fraser,
1999). Secondly, a neural crest origin may better account
for the recent reports suggesting the existence of MSCs
with neurogenic potential (Dezawa et al., 2001; Kopen
et al., 1999). More recently, Fernandes et al. suggested
the presence of multipotent stem cells in the hair papilla,
which derive from neural crest (Fernandes et al., 2004).
The question of which of those MSCs is of neural crest
origin is an important issue for future research. In this
respect, our data suggest that, while some MSC lines es-
tablished from embryos may be derived from neural crest
cells, it is unlikely that MSCs established from adult bone
marrow are of neural crest origin. Moreover, we showed
that PDGFRb can be exploited as another marker of
MSC that are restricted to mesenchymal cell lineage.
In conclusion, in this study we have defined the first
wave of MSC differentiation by identifying the origin and
intermediate stages of its differentiation, thereby demon-
strating that MSCs are an actual tissue component rather
than an in vitro artifact. Although the origin of the later
waves remains for future study, this study will open a
new avenue in the understanding of the behavior and
role of MSCs.
EXPERIMENTAL PROCEDURES
Cell Culture
A variety of culture methods were required for this study such as ES
cell differentiation, MSC culture, cultures for MSC differentiation to
mature mesenchymal cells, CFU-F assay, neurosphere culture and
oligodendrocyte differentiation culture. All details including ingredients
in media are described separately in the Supplemental Experimental
Procedure as well as in our previous papers cited in the reference.
We exploited only monolayer culture of ES cells for inducing differen-
tiation. Thus, while the original method of ES cell differentiation to ad-
ipocytes exploited the embryoid bodymethod (Dani et al., 1997), it was
modified into the monolayer culture. ES cell lines used in this study are
CCE, TT2 and ES-Sox1gfp/+ lines.
Injection of Tetraploid Embryos
Tetraploid embryo complementation was performed as described
(Nagy et al., 1993), using C57BL/6 zygotes. Briefly, two-cell stage em-
bryos were electro-fused and developed in vitro to the 4N blastocyst
stage. ES-Sox1gfp/+ cells were injected into blastocysts and trans-
ferred to pseudo-pregnant ICR females. At E9.5, the embryos were
collected and those expressing GFP were selected for further use.
Mouse Stains Used for Cell Tracing
The Sox1-Cre knock-in strain was produced by homologous recombi-
nation by the targeting vector (Supplemental Data2A and Supplemen-
tal Experimental Procedure) into TT2 ES cells. Transient transfection
with a Flp-expressing recombinant adenovirus was performed to re-
move the PGK-Neo cassette (Kondo et al., 2006). The absence of
PGK-Neo cassette was confirmed by Southern blot analysis. P0-Cre
mice and ROSA26R-EYFP mice were kindly provided by Ken-Ichi
Yamamura and Frank Costantini, respectively. PCR genotyping of
mice was performed by using primers listed in Figure S7.
Preparation of Single-Cell Suspension
Culture cells were dissociated by tryposin-EDTA or dissociation buffer
(GIBCO). To prepare cells from embryo, the trunk region indicated in
Figure 3 were pooled, minced, and incubated first with 2.4U dispase II
in PBS (GIBCO) and subsequently dissociation buffer (GIBCO). To ob-
tain bone cell suspension, femurs and tibias were removed, cut into
small pieces, and treated with 0.2% collabenase (SIGMA) and 2.4U
dispase II (GIBCO) at 37C for 1hr with gentle agitation. Neonate and
adult brain were minced and the fragments were treated with 0.05%
Trypsin/EDTA (GIBCO) for 15min at 37C. Cells were stained with fluo-
rescence labeled antibodies and sorted or analyzed by FACS Aria
(Becton & Dickinson) and FACS Calibur (Becton & Dickinson) was
used.
Immunohistochemistry
For histological analysis, embryos were fixed in 4% paraformaldehyde
overnight and embedded in cryomold for sectioning. The following an-
tibodies were used as primary antibodies: APA5, 1:1000 or anti-p75 Ab
(Chemicon), 1: 200; anti-GFP(NACALAI), 1:500. TO-PRO3 iodide (Invi-
trogen) was used for nuclear staining. Samples were stained by appro-
priate fluorescence-tagged secondary antibodies and examined using
a Radiance 2100 (BioRad) confocal imaging system. For Ki67 staining,
the cytospinned cells were first incubated with anti-Ki67 (ABCAM) at
1/500 dilution. For statistical analysis, 250 cells were examined in
each experiment.
RT-PCR Assay
RT-PCR was performed as described previously (Tada et al., 2005).
We used b-actin expression as a control. Primers used for RT-PCR
assay is listed in Figure S7.
Supplemental Data
Supplemental Data include seven figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this
article online at http://www.cell.com/cgi/content/full/129/7/1377/
DC1/.
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